Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma.
Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma.
复制标题
DOI:
10.3389/fonc.2021.737127
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Yue X
中科院分区:
文献类型:
--
作者:
Lu J;Zhang Y;Sun M;Ding C;Zhang L;Kong Y;Cai M;Miccoli P;Ma C;Yue X
Papillary thyroid carcinoma (PTC) accounts for the majority of thyroid cancer and affects a large number of individuals. The pathogenesis of PTC has not been completely elucidated thus far. Metabolic reprogramming is a common feature in tumours. Our previous research revealed the reprogramming of lipid metabolism in PTC. Further studies on lipid metabolism reprogramming may help elucidate the pathogenesis of PTC. Clinical samples of PTC and para-tumour tissue were analysed using lipidomic, proteomic, and metabolomic approaches. A multi-omics integrative strategy was adopted to identify the important pathways in PTC. The findings were further confirmed using western blotting, tissue microarray, bioinformatics, and cell migration assays. Multi-omics data and the results of integrated analysis revealed that the three steps of fatty acid metabolism (hydrolysis, transportation, and oxidation) were significantly enhanced in PTC. Especially, the expression levels of LPL, FATP2, and CPT1A, three key enzymes in the respective steps, were elevated in PTC. Moreover, LPL, FATP2 and CPT1A expression was associated with the TNM stage, lymph node metastasis of PTC. Moreover, high levels of FATP2 and CPT1A contributed to poor prognosis of PTC. In addition, ectopic overexpression of LPL, FATP2 and CPT1A can each promote the migration of thyroid cancer cells. Our data suggested that enhanced fatty acid metabolism supplied additional energy and substrates for PTC progression. This may help elucidating the underlying mechanism of PTC pathogenesis and identifying the potential therapeutic targets for PTC.
登录
查看更多内容
影响因子:
5.7
作者:
Kuemmerle NB;Rysman E;Lombardo PS;Flanagan AJ;Lipe BC;Wells WA;Pettus JR;Froehlich HM;Memoli VA;Morganelli PM;Swinnen JV;Timmerman LA;Chaychi L;Fricano CJ;Eisenberg BL;Coleman WB;Kinlaw WB
通讯作者:
Kinlaw WB
影响因子:
3.5
作者:
Heinzer, AK;Watkins, PA;Smith, KD
通讯作者:
Smith, KD
DOI:
10.1186/s40880-018-0301-4
发表时间:
2018-05-21
期刊:
Cancer communications (London, England)
影响因子:
--
作者:
Cheng C;Geng F;Cheng X;Guo D
通讯作者:
Guo D
影响因子:
11.8
作者:
Hoffman, Kate;Lorenzo, Amelia;Sosa, Julie Ann
通讯作者:
Sosa, Julie Ann
影响因子:
11.2
作者:
Migita, Toshiro;Narita, Tadahito;Ishikawa, Yuichi
通讯作者:
Ishikawa, Yuichi